Fundraising FoxNeuronascent
Clarksville, US · Maryland corporation
Find your way into Neuronascent
Sign up to see every warm intro you have to Neuronascent
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuronascent team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuroNascent develops therapeutics aimed at generating new neurons and regenerating existing ones to treat neurological disorders. Its R&D pipeline targets conditions including Alzheimer's disease, Parkinson's disease, and developmental delay, alongside a veterinary medicine program.
Founders & leadership
JK
Judith Kelleher-AnderssonFounderFounder and President of NeuroNascent, Judith Kelleher-Andersson has directed research programs at multiple biotech companies and is developing small molecule therapeutics targeting central nervous system disorders including Alzheimer's disease and Parkinson's disease.
Board
RO
Robin OegerleBoard director
MG
Maurice GagnonBoard director
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 1 round · 2015
▶$1.2MraisedMar 2015 · 1 investors · Other Health CareRule 506(b)
▶$1.2MraisedMar 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robin OegerleDirector
- Maurice GagnonDirector
- Judith Kelleher-AnderssonExecutive Officer, Director
- Kathleen MattisExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.2M
- Minimum investment
- $112.5K
- First sale
- Mar 2015
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Neuronascent.
In the news
Frequently asked questions
- What does Neuronascent do?
- NeuroNascent develops therapeutics aimed at generating new neurons and regenerating existing ones to treat neurological disorders. Its R&D pipeline targets conditions including Alzheimer's disease, Parkinson's disease, and developmental delay, alongside a veterinary medicine program.
- Who founded Neuronascent?
- Neuronascent was founded by Judith Kelleher-Andersson.
- How much funding has Neuronascent raised?
- Neuronascent has disclosed $1.2M raised across 1 round.
- Where is Neuronascent headquartered?
- Neuronascent is headquartered in Clarksville, US.